155 related articles for article (PubMed ID: 35277428)
1. The impact of the COVID-19 pandemic among migrants in shelters in Tijuana, Baja California, Mexico.
Bojorquez-Chapela I; Strathdee SA; Garfein RS; Benson CA; Chaillon A; Ignacio C; Sepulveda J
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35277428
[TBL] [Abstract][Full Text] [Related]
2. The epidemiological follow-up process for suspected and confirmed cases of COVID-19 in migrant shelters on the northern border of Mexico from July to December 2020: Between contagion underestimation and containment.
Rangel Gómez MG; Cruz-Piñeiro R; Cappelletti V; López Jaramillo AM
Front Public Health; 2022; 10():980808. PubMed ID: 36711368
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.
Strathdee SA; Abramovitz D; Harvey-Vera A; Vera CF; Rangel G; Artamonova I; Chaillon A; Ignacio C; Calderon A; Martin NK; Patterson TL
PLoS One; 2021; 16(11):e0260286. PubMed ID: 34807963
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 infection and impact of the COVID-19 pandemic in avocado farmworkers from Mexico.
Armendáriz-Arnez C; Tamayo-Ortiz M; Mora-Ardila F; Rodríguez-Barrena ME; Barros-Sierra D; Castillo F; Sánchez-Vargas A; Lopez-Carr D; Deardorff J; Eskenazi B; Mora AM
Front Public Health; 2023; 11():1252530. PubMed ID: 38174080
[TBL] [Abstract][Full Text] [Related]
5. Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border.
Chaillon A; Bojorquez I; Sepúlveda J; Harvey-Vera AY; Rangel MG; Skaathun B; Mehta SR; Ignacio C; Porrachia M; Smith DM; Strathdee SA
Salud Publica Mex; 2023 Jan; 65(1, ene-feb):10-18. PubMed ID: 36750073
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 testing, infection, and vaccination among deported Mexican migrants: Results from a survey on the Mexico-U.S. border.
Martínez-Donate AP; Correa-Salazar C; Bakely L; González-Fagoaga JE; Asadi-Gonzalez A; Lazo M; Parrado E; Zhang X; Rangel Gomez MG
Front Public Health; 2022; 10():928385. PubMed ID: 35968453
[TBL] [Abstract][Full Text] [Related]
7. Risk of SARS-CoV-2 infection in migrants and ethnic minorities compared with the general population in the European WHO region during the first year of the pandemic: a systematic review.
Jaljaa A; Caminada S; Tosti ME; D'Angelo F; Angelozzi A; Isonne C; Marchetti G; Mazzalai E; Giannini D; Turatto F; De Marchi C; Gatta A; Declich S; Pizzarelli S; Geraci S; Baglio G; Marceca M
BMC Public Health; 2022 Jan; 22(1):143. PubMed ID: 35057781
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
10. The Impact of the Covid-19 Pandemic and the Lockdown on the Health and Living Conditions of Undocumented Migrants and Migrants Undergoing Legal Status Regularization.
Burton-Jeangros C; Duvoisin A; Lachat S; Consoli L; Fakhoury J; Jackson Y
Front Public Health; 2020; 8():596887. PubMed ID: 33392134
[No Abstract] [Full Text] [Related]
11. Prevalence of SARS-CoV-2 infection in Baja California, Mexico: Findings from a community-based survey in February 2021 in the Mexico-United States border.
Zazueta OE; Garfein RS; Cano-Torres JO; Méndez-Lizárraga CA; Rodwell TC; Muñiz-Salazar R; Ovalle-Marroquín DF; Yee NG; Serafín-Higuera IR; González-Reyes S; Machado-Contreras JR; Horton LE; Strathdee SA; Rodríguez R; Hill L; Bojórquez-Chapela I
PLOS Glob Public Health; 2022; 2(8):e0000820. PubMed ID: 36962566
[TBL] [Abstract][Full Text] [Related]
12. How Did the COVID-19 Pandemic Affect Migrant Populations in Lisbon, Portugal? A Study on Perceived Effects on Health and Economic Condition.
Gama A; Rocha JV; Marques MJ; Azeredo-Lopes S; Pedro AR; Dias S
Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162809
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 antibodies among homeless people living rough, in shelters and squats: A large population-based study in France.
Loubiere S; Monfardini E; Allaria C; Mosnier M; Allibert A; Ninove L; Bosetti T; Farnarier C; Hamouda I; Auquier P; Mosnier E; Tinland A
PLoS One; 2021; 16(9):e0255498. PubMed ID: 34525096
[TBL] [Abstract][Full Text] [Related]
14. Interrupted transit and common mental disorders among migrants in Tijuana, Mexico.
Bojorquez I; Sepúlveda J; Lee D; Strathdee S
Int J Soc Psychiatry; 2022 Aug; 68(5):1018-1025. PubMed ID: 35652311
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
16. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
Aissatou A; Fokam J; Semengue ENJ; Takou D; Ka'e AC; Ambe CC; Nka AD; Djupsa SC; Beloumou G; Ciaffi L; Tchouaket MCT; Nayang ARM; Pabo WLT; Essomba RG; Halle EGE; Okomo MC; Bissek AZ; Leke R; Boum Y; Mballa GAE; Montesano C; Perno CF; Colizzi V; Ndjolo A
Front Immunol; 2023; 14():1155855. PubMed ID: 37090738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Evaluation of the Impact of Sociodemographic Inequalities on Adverse Outcomes and Excess Mortality During the Coronavirus Disease 2019 (COVID-19) Pandemic in Mexico City.
Antonio-Villa NE; Fernandez-Chirino L; Pisanty-Alatorre J; Mancilla-Galindo J; Kammar-García A; Vargas-Vázquez A; González-Díaz A; Fermín-Martínez CA; Márquez-Salinas A; Guerra EC; Bahena-López JP; Villanueva-Reza M; Márquez-Sánchez J; Jaramillo-Molina ME; Gutiérrez-Robledo LM; Bello-Chavolla OY
Clin Infect Dis; 2022 Mar; 74(5):785-792. PubMed ID: 34159351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
